Replies to post #43 on Biotime

[investment_mgr]

I used to own GERN and sold into a spike at 6 and change. I always had a problem with management for starters. That was confirmed a few weeks ago I believe as there was a shakeout in that regard if I am not mistaken.

Also, their ip has been trumped and they have patent problems. I believe BTX actually has a backdoor into GERN's ip through one of their acquisitions, not to mention, much better bis strategies and tech of their own.

GERN became complacent, and simply could not get it done, and the field is passing them by.

BTX and ISCO are the ways to go. I don't own ISCO right now, but did, and will again. I have spec shares in ACTC, but nothing substantial.

I also like CUR, but, not at this time, likely to go lower.

IM